» Articles » PMID: 1825582

The Effects of a 5-lipoxygenase Inhibitor on Antigen-induced Mediator Release, Late-phase Bronchoconstriction and Cellular Infiltrates in Primates

Overview
Date 1991 Jan 1
PMID 1825582
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Inhaled BI-L-239 significantly inhibited i-LTC4 generation, late-phase bronchoconstriction and the influx of neutrophils into the lungs. We conclude that leukotriene generation and release within the lungs, following allergen exposure, in part mediate altered lung function and contribute to the development of airway inflammation. As such, treatment with a selective 5-lipoxygenase inhibitor may aid in the treatment of bronchial asthma and other allergic diseases.

Citing Articles

A PAF receptor antagonist inhibits acute airway inflammation and late-phase responses but not chronic airway inflammation and hyperresponsiveness in a primate model of asthma.

Gundel R, Wegner C, Heuer H, Letts L Mediators Inflamm. 1992; 1(6):379-84.

PMID: 18475488 PMC: 2365364. DOI: 10.1155/S0962935192000577.


The effect of 5-lipoxygenase inhibition on Ascaris antigen (Ag)-induced responses in atopic monkeys.

Turner C, Smith W, Andresen C, Eggler J, Watson J Inflamm Res. 1996; 45(1):42-9.

PMID: 8821778 DOI: 10.1007/BF02263504.


Characterization of a primate model of asthma using anti-allergy/anti-asthma agents.

Turner C, Andresen C, Smith W, Watson J Inflamm Res. 1996; 45(5):239-45.

PMID: 8737747 DOI: 10.1007/BF02259610.